N-0877
/ Eurofarma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 01, 2025
Final Report on NCCTG N0877 (Alliance): A Phase II Randomized, Placebo-Controlled Trial of Chemoradiotherapy with or without Dasatinib for Glioblastoma.
(PubMed, Neuro Oncol)
- "The addition of dasatinib to standard chemoradiation did not improve outcomes for patients with glioblastoma."
Journal • P2 data • Brain Cancer • Glioblastoma • Hematological Disorders • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1